Bain Capital, LP is one of the world’s leading private investment firms with approximately $185 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact

Shuvam Chaudhuri, PhD

Shuvam Chaudhuri, PhD

Life Sciences


Dr. Chaudhuri joined Bain Capital Life Sciences in 2023. He was previously a Bain Capital Life Sciences Fellow. 

Prior to joining Bain Capital, Dr. Chaudhuri performed his doctoral research at Northwestern University where he studied transcriptional mechanisms governing immune cell differentiation across the contexts of cancer, infection, and autoimmunity. Before graduate school Dr. Chaudhuri performed research in the antiviral drug discovery group at Janssen Research and Development. 


Dr. Chaudhuri received his PhD in Biomedical Sciences with a focus in immunology from Northwestern University. He graduated with a BS in Molecular Biology and minor in Business Administration from the University of Washington.